{"id":53384,"name":"VHL ALLIANCE","slug":"vhl-alliance","state":"MA","country":"United States of America","description":"federal research funding for von Hippel-Lindau (VHL) disease.","totalSpending":140000,"filings":15,"yearlySpending":[{"year":2022,"income":10000},{"year":2023,"income":50000},{"year":2024,"income":40000},{"year":2025,"income":40000}],"issues":["BUD","DEF","MED"],"firms":["CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C."],"lobbyists":["MARK VIETH"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FY23 Defense Appropriations Act, research funding for von Hippel-Lindau (VHL) disease. National Institutes of Health funding for VHL disease.","FY23 Defense Appropriations Act, research funding for von Hippel-Lindau (VHL) disease. National Institutes of Health funding for VHL disease.","FY23 Defense Appropriations Act, research funding for von Hippel-Lindau (VHL) disease. National Institutes of Health funding for VHL disease.","HR 2617, PL 117-328, Consolidated Appropriations Act, Fiscal year 2023, DoD research on Von Hippel-Lindau syndrome","HR 2617, PL 117-328, Consolidated Appropriations Act, Fiscal year 2023, DoD research on Von Hippel-Lindau syndrome"],"years":[2022,2023,2024,2025]}